These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24674455)

  • 1. Can physical exercise or food deprivation cause release of fat-stored cannabinoids?
    Westin AA; Mjønes G; Burchardt O; Fuskevåg OM; Slørdal L
    Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):467-71. PubMed ID: 24674455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
    Schwilke EW; Gullberg RG; Darwin WD; Chiang CN; Cadet JL; Gorelick DA; Pope HG; Huestis MA
    Addiction; 2011 Mar; 106(3):499-506. PubMed ID: 21134021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
    J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
    Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal indication of cannabis use by means of THC glucuronide determination.
    Mareck U; Haenelt N; Geyer H; Guddat S; Kamber M; Brenneisen R; Thevis M; Schänzer W
    Drug Test Anal; 2009 Nov; 1(11-12):505-10. PubMed ID: 20355165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
    Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
    Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Himes SK; Chen X; Liu HF; Huestis MA
    Anal Bioanal Chem; 2013 Jul; 405(18):6019-27. PubMed ID: 23681203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
    Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
    Kraemer M; Madea B; Hess C
    Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
    Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Four Cannabinoids in Umbilical Cord Tissue.
    Wu F; Scroggin TL; Metz TD; McMillin GA
    J Anal Toxicol; 2018 Jan; 42(1):42-48. PubMed ID: 28977394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.